Adaptations of cytoarchitecture in human dilated cardiomyopathy

Marlene Pluess1, Gregor Daeubler1, Cristobal G Dos Remedios2

  • 1Randall Division of Cell and Molecular Biophysics and Cardiovascular Division, British Heart Foundation Centre of Research Excellence, King's College London, New Hunt's House, Guy's Campus, London, SE1 1UL, UK.

Biophysical Reviews
|May 17, 2017
PubMed

Insights

Dilated cardiomyopathy (DCM) involves altered heart cell structures, including the intercalated disc and sarcomere M-band. These cytoarchitectural changes in cardiomyocytes likely contribute to reduced heart function in DCM patients.

Area of Science:

  • Cardiovascular Biology
  • Cellular Cardiology
  • Cardiac Pathology

Background:

  • Dilated cardiomyopathy (DCM) presents with fibrosis and necrosis, unlike the myocyte disarray typical of hypertrophic cardiomyopathy.
  • Previous research explored subcellular cytoarchitectural alterations in mouse models of DCM.

Purpose of the Study:

  • To investigate subcellular alterations in the cytoarchitecture of heart cells in dilated cardiomyopathy (DCM).
  • To analyze changes in the intercalated disc and sarcomere M-band composition.
  • To examine cardiomyocyte size control in human DCM samples.

Main Methods:

  • Analysis of subcellular structures in mouse models of DCM.
  • Investigation of intercalated disc organization and composition.
  • Examination of sarcomere M-band composition, focusing on myomesin isoforms.
  • Analysis of human heart tissue samples from the Sydney Human Heart Tissue Bank.

Main Results:

  • Significant alterations were found in the organization and composition of the intercalated disc in DCM.
  • A shift in M-band composition towards the embryonic heart (EH)-myomesin isoform was observed.
  • Human DCM samples showed similar structural findings to mouse models.
  • Evidence of dramatic changes in cardiomyocyte size control was found in human DCM samples.

Conclusions:

  • Alterations in intercalated disc and M-band composition are key features of DCM cytoarchitecture.
  • Changes in cardiomyocyte size control contribute to DCM pathology.
  • These cytoarchitectural modifications likely underlie the decreased functional output observed in DCM.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
677
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
578
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
704
Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
18.2K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
551
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K